Comments. . 1541401. Release Date: 27/06/22 09:19; Summary: SPL signs expanded DEP research agreement with US Biopharma; Price Sensitive: Yes; Download Document 194. 6% (1. 0. They are the future as also mentioned regularly by Eric Topol. Market . Our magic little formula may just be the answer. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . opportunities galore IMO but we are likely to miss the boat again based on past performance of JF & Co. 0¢. 0¢. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . New Zealand Dollar. Some links within this article worth a scan too. 15667. I think that the more time that passes without profits, the less likely that there will ever be profits. . I just hope that Starpharma shareholders sit up and notice at how the leaders of our company (the Chairman and CEO). ASX - By Stock. . 00%. rights. As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). 5¢. Created with Sketch. Latest Posts. my apologies that I could not stay after the. ASX - Day Trading. SPL Ann: Application for quotation of securities - SPL SPL starpharma holdings limited Ann: Application for quotation of securities - SPL ASX News 851. 37. Starpharma (SPL) Shares in the nano-biotechnology group bucked the falls in the wider market on Monday after it announced a deal with a division of US pharmaceutical giant Ely Lilly to extend the application of its technologies in the animal health area. ROFL. 9¢. It knows of Viraleze - so its rationale for letting Viraleze meander through regulatory processes with no due haste or intervention is mystifying. I think with SPL we are up to series 10 episode 100!!!! and I do laugh a lot mostly at posters naiviety On your part pretty poor form comparing such a classic comedy with such a tragic live comedy watched on the market everyday !!Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. 3. Last updated 15. Share I sometimes wonder if they actually work at Starpharma. 9¢. Latest Posts. Cristal therapeutics. Jackie in the discussion talked about dealing with the tourist industry. Name/company Polymer Drug, class/loading method Delivery system type/size Clinical stage/indication; CPC634. Offers an alternative as reasons for delays, been at the mercy of regulators playing catch-up somewhat. The upper and lower pennant lines will intersect in three months. . Although with SPL's track record an exceptionally good news announcement seems unlikely, it is within the realms of possibility - and this seems to be what makes SPL worth a gamble. ASX - By Stock. . Overview. Notice to Sellers of Vapour Products – PST Rate Increase to 20% Page 3 of 3 Need more info? Online: gov. Become a member of Australia's largest investment discussion forum. Slow golf clap for Jackie Fairley. Surely, surely these great technical achievements will translate into commercial gains for the company and us long suffering SPL Shareholders. The digital display offers a 0. ASX - By Stock. I sold out of my position in SPL at that time precisely because of this. 0 Great. I am STILL inviting comment on SPL and their Zika proclamations, and how this is evidence of SPL’s long standing crumb throwing method. Let's not forget that this happened due to the poor performance of management that contributed to SPL getting the boot from. SPL. Latest Posts. SPL has on multipleoccasions used COVID as an excuse for expanded timelines on active trails andto my understanding SPL has also been receiving support from the governmentduring COVID. Join the HotCopper ASX share. Last updated 15. 8%. ASX - General. Timeline. it certainly is a confidence booster to keep on topping upGood luck with whatever investments you may hold at the moment, and if you’re still in SPL, hopefully it will get a bit of a bounce soon. Volume. I’ve seen numerous cases across Hotcopper where a shareholder with a large investment will say whatever it takes, over a sustained period of years, even though it may be highly optimistic, knowingly false or misleading, in an attempt to protect their own investment, even at the expense of other less experienced Hotcopper members and investors. The matter has been adjourned to. 22%) 3,361,416 was the lowest point of total short sales for some years as of 15/06/23 (0. ASX - By Stock. Latest Posts. caBC OnLine Partnership Office E161, 4000 Seymour Place PO Box 9412, Stn Prov Govt Victoria, BC V8W 9V1Share. 6% downward extention down to (0. ASX - Day TradingHi guys, I have held SPL shares for over 9 years and I will continue to hold. They need IMO to define good and any other qualifying words !!. As always, she is happy to hoover up freebie shares in the grandiose remuneration agreements as well as collect performance bonuses as disclosed in the Annual Report. So much coming up with Viraleze and DEP Starpharma team will be working very hard at the moment with so many balls in the air. Created with Sketch. Below are 3 charts showing the predictions for Starpharma's Price by End 2019. 5. OR no reponse at all. 138. Market Cap $57. SPL's current SP is about 15 cents, after many years (some say 20 years) of unprofitability, during which time substantial salaries and performance bonuses appear to have been paid. Last updated 15. I am closely watching the state of the World Economy, particularly China and the U. 3¢. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. . Latest Posts. Latest Posts. Twenty years later it’s 84. Advertise on HotCopper. Working in a. Join the HotCopper ASX share market forum today for free. Pre-clinical results from a DEP HER2-Lutetium breast cancer model (see link below) were released by SPL in March 2021 with no update or published advancement since this announcement, and no deal/licence forthcoming. 70 Sentiment: Sell Disclosure: Held Not only did AZ not announce completion of Phase 1 with stellar results, the commencement of Phase 2 and a big milestone payment to SPL as the pompom brigade were postulating, it was just interim Phase 1 results and dose escalation apparently continues. 0¢. 48. AZ will be watching Phase 2 results and assessing the market against the potential SPL bill. Enquire Now & Supercharge Your Brand with HotCopper 17 Oct 2023. . Surely the political restraints. 52 (16th Feb) on the back of the hype that surrounded the launch of VIRALEZE in UK/EU/WORLD. We have oft heard the CEO brag about the $1B+ value of the AZD0466 milestones and license revenues. I no longer regard SPL as an investment-grade stock. bc. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . . Phillip Altman is a highly-respected and well-known Australian authority on clinical trials and drug regulatory affairs with more than 40 years of experience in designing, managing and reporting of clinical trials and in working with the Australian Therapeutic Goods Administration (TGA) in gaining new drug approvals. ASX - By Stock. 16,161,259. . Created with Sketch. Last updated 15. Charts. Latest Posts. If only SPL management would undertake Human Trials for Viraleze ? The experts are leaning towards more nasal spray use including as vaccines but our management are too busy organising their free shares. On the subject of upfront licence fees Bell Potter in one of their analyses on SPL several years ago gave estimates of the likely upfront fees at $15M for Dep Doc, $8M for Dep Cab & $30M for Dep Irin. Created with Sketch. RDN Raiden Resources secures complete control of lithium at Arrow Project, buys out Arrow Minerals Ltd. Created with Sketch. 1. Join the HotCopper ASX share market forum today for free. Created with Sketch. The news flow coming from SPL of latehas been lackluster at best. ASX - General. Join the HotCopper ASX share market forum today for free. Zeus Resources Limited is an Australia-based mineral exploration company. But I’ve been having a. Charts. HotCopper has news, discussion, prices and market data on TRIGG MINERALS LIMITED. )” ~@antibotter Jan 2019 (Hotcopper post #37005569) After ASX announcement ‘Positive DEP phase 2 interim results in prostate cancer’: SPL are obliged to make announcements and unfortunately they have not included enough detail so shareholders are aware of timings and actual release in Indonesia nor real scale. . I will be unable to listen to the AGM but look forward to listening to the audio and reading Hotcopper comments and feed back after my afternoon shift. Hi all, I think it would be in all of our best interests if each of us sent an email to SPL investor relations and voiced our concerns. Market . distraction achieved. 56. ASX - General. SPL is not a penny dreadful (not yet anyway) and it is not a resources company and it has enough funds to last a few more years even if it never makes a cent. . You got to wonder after huge volumes going through last 4 days and the SP reaching new lows. So SPL did the one thing they could to challenge the TGA they sent it to adjudication and TGA were told Feb 22 - you must accept application as medical device and SPL announced to ASX in April 22 that their application was in. A trader who used stock forum HotCopper to pump and dump about 20 penny stocks using 13 trading accounts has been given a jail term of 2½ years, but is being released immediately on a five-year. Forums. 0¢. 70. 52 (16th Feb) on the back of the hype that surrounded the launch of VIRALEZE in UK/EU/WORLD. , page-4. See All Discussions. Even Pfizer won’t comment on him. I find it alarming the number of column inches in the resolution explanatory notes, extolling their experiences prior to spl, when not one of them has any achievements in the advancement of spl listed. 8¢. The 407730 is a sound level meter that measures from 40 to 130dB with an accuracy of 2dB. Their IP doesn't last forever - you need to hustle in pharma. Looking at the short term, SPL's SP is currently perched above a technical support line at 50 cents. And he still is Chairman or Director of SIX other companies. ASX - Day TradingTime to top up again for me What about youBetween Oct 2017 and Mar 2018 it seemed like we held pretty consistently above $1. A new DFS upgrade has expanded operation capacity on-site the project from 15 gigawatt hour’s worth of battery production to 120GWh. I'd think that SPL will be covering all the bases required for a crack at 505b2, but with the necessary data to pivot to a phase 3 trial if. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. The results will be good but will they be good enough for SPL to be able to do the deals. As of 2015, HotCopper was in the top 170 websites in Australia and was. $0. HotCopper is Australia's largest free and independent stock market trading forum for ASX investors to discuss share prices, the stock market and more. SPL is tanking, HQ are overpromising and under delivering. Created with Sketch. Ineffective deals and sloppy clinical trials and regulatory tactics might be able to be gloss over for years but over times it show in the bottom line. Click for more information. ASX - By Stock. The bait SPL have put out about models and publishing in 3 weeks should be stopped by ASX / ASIC and teh timing is odd IMO. 0. Share Many media conferences during the Pandemic we heard of Victorian initiatives for covid treatments or preventative by Dan Andrews or Brett Sutton - so VICTORIA has questions to answer. Join the HotCopper ASX share market forum today for free. Created with Sketch. 0834. Even if these collaborations have beenterminated, the market deserves to know about it. 50 or. Starpharma was 96 cents in April 2002. Forums. 0. . I saw that some director etc invested there own money in the SPP etc,. Created with Sketch. Target our investor community with our suite of Hotcopper Advertising opportunities. Join the HotCopper ASX share market forum today for free. SPL always has tantalising carrots to dangle before the eyes of investors. Starpharma is listed on the Australian stock exchange (ASX:SPL). and the Government Medical Research Fund which provided $1mil to SPL to aid in developing Viraleze. Last updated 15. J K Fairley $1,272,084N J Baade. . I hope I'm wrong here. 19/09/23. . The rules obviously do not apply in Starpharma Land with CEO Jackie Fairley. ASX - Day Trading SUBMISSION STEPS. If only we had the viraleze. I remember seeing a post on SPL had 41000 views. Safety, tolerability and side effects appear to be superior to all the base drugs, and that should be enough to sell the licenses. HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. Labcorp Contacts: Media: Michele Mazur — 336-436-8263 Media@Labcorp. , page-2. Forums. 0¢ STARPHARMA HOLDINGS LIMITED - Discussion. by other companies i meant those associated with SPL, and ask what up from their end. ASX - By Stock. 0¢. 52pm 13/10/2023 ? HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. ASX - Day Trading. 5¢. 8985. We would like to show you a description here but the site won’t allow us. 8¢. Created with Sketch. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. ASX - Day Trading. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . 0 Created with. As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). Viraleze being 1% less efficacious against the more potent dangerous new strains is an awesome result and should be celebrated. any other information the entity wishes to notify to ASX about the cessation?The Performance Rights issued under an employee incentive scheme lapsed during the course of the quarter ended 30June 2023 include 519,053 Rights held by KMP, Nigel Baade, and 310,760 Rights held by non-KMPs. NEW YORK TRANSN DEV CORP SPL FAC REV 4. The Scripps in-vivo evidence using genetically engineered mice only became available to the November TGA conference at which such matters are. 0834. HotCopper has news, discussion, prices and market data on SPLITIT PAYMENTS LTD. Created with Sketch. Last post JoeSalami. ASX - By Stock Forum | Join the HotCopper forum today for free. Latest Posts. 6. Forums. . . Your missing the signals guys/gals looking too much at Viraleze, other products, CEO, BOD etc, read the signals my friend's there is a major DEP Move in. . Despite the length of time that SPL has been in existence, it is obvious that some players think that SPL is currently overvalued, hence the relentless selling. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. I should declare that I am. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . ASX - Day TradingLast day Spl remains in ASX300 Institutions and/or shorters buying TIME LINE At auction today there were 20 million shares wanted to buy and 11 millions shares wanted to sell Notice after close of auction there were still 10 million shares wanted to buy and 450k to sellThe deal, which has an initial duration of 12 months, has the same terms as the previous agreement. Latest Posts. In part it oversees accelerated research initiatives to develop responses to unmet needs. SPL conducts a "trial" (use that word loosely) in of all places WA !! Yet our commercial hotshots cannot arrange a deal with a WA based company who appear highly capable and connected in getting distribution to sought after sectors like "Allied Health practitioners, the corporate sector and government". ASX - By Stock. Market. ASIC said Govinda faces a maximum penalty for each charge of 10 years’ prison, or a fine of up to $765,000, or both, after he entered the guilty pleas on Monday. $0. ASX - Day Trading. . . Click for more information. 0%. Forums. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. I know that Company's have to concentrate on the task at hand but an awareness of the World Economy is important. Both were very well paid and, if the "forward looking statements" are to be believed would have had the box seat in a company with a great future. ASX - Short Term Trading. 63M. 0. Join the HotCopper ASX share market forum today for free. Hey, "smart", I concur with your message. . Created with Sketch. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Just as I thought - both @antibotter and JF & Co. Last updated 15. ASX - Day Trading Last day Spl remains in ASX300 Institutions and/or shorters buying TIME LINE At auction today there were 20 million shares wanted to buy and 11 millions shares wanted to sell Notice after close of auction there were still 10 million shares wanted to buy and 450k to sell Merck has tightened its ties to Starpharma as it continues to build out its antibody-drug conjugate (ADC) capabilities, signing a second agreement that will enable it to evaluate candidates based. Once they think they can get AZD0466 to market they will pounce if our share price is less tan $2. ASX - Day TradingMelbourne, Australia; 6 May 2021: Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that VIRALEZE™ antiviral nasal spray is now available for purchase by consumers in Europe via Starpharma’s webstore. 3¢. 1. DJPIN. Share Great ad I think it will boom in Hong Kong under the Banitore Manning name, despite what the naysayers say Banitore have a big presence in China their manufacturing of health products is also in China I would imagine they have significant pull in China and other regions, In my opinion Viraleze is set to be a huge world product in tome. Maybe SPL is frustrated at the lack of promotion, or maybe they have frustrated McKesson with continuity of supply, but I doubt it this early in the relationship - the logistics will be guided by demand, and it takes time to find the right equilibrium without overcommitting funds and/or scaling up manufacturing capacity, honouring contracts etc. Created with Sketch. Imo HotCopper posters must have an. 5. . 5¢. If SPL come out with more data and partners or a potential pathway to sales, great, i will change my view and the price will likely spike. SPL Price at posting: 16. While the chart is not good there is a glimmer hope maybe emerging. With EOFY selling about to hit us like a freight train, where does everyone think the bottom will be for SPL' shareprice?Unless one of the many promises. Hey, "smart", I concur with your message. 72. Resolutons 2,3 &4. 59pm 20/11/2023 ? HotCopper has news, discussion, prices and market data on PANCONTINENTAL ENERGY NL. It is because SPL has abrogated the marketing role to its distributors. Share Interesting points John Some institutions might accept anything over $1. . The thread is titled so that it can be found and general enough so as to. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . I am not up to date with all brexit stuff let alone othe rcountries like Vietnam , HK and very cautiious about consultants websites and simply govt websites area nightmare to understand and navigate unless it is your speciality. Last updated 15. . “It wouldn't surprise me if Starpharma have and are talking with big pharma in a joint collaboration to further develop SPL7013 for other. Join Australia’s largest community of ASX investors and share market enthusiasts in our free and independent stock market forum. 5¢ STARPHARMA HOLDINGS LIMITED - Discussion. CEO knows it is all going. Join the HotCopper ASX Stock discussion forum for STARPHARMA HOLDINGS LIMITED. Created with Sketch. great news but unlikely. Advertise on HotCopper. . Join the HotCopper ASX share market forum today for free. ASX - By Stock. . Not going to go over all the posts that are detailing what the spl7013 antiviral nasal spray may mean to the world others have done a great job. 616553. . ASX - By Stock. 15. SPL. 63. Follow your favourite stocks, view charts, track gainers and losers and discuss topics including politics, commodities, cryptocurrency and managed funds. Advertise on HotCopper. ASX - By Stock. 22/9/2000 CSL $11. ASX - By Stock. 58pm 20/10/2023 ? HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. Model # 407730 Store SKU # 1000846365. 5¢. That won’t be a shock to. Created with Sketch. Disowned him really. ASX - Day Trading So the share price of SPL rose up to a high of $2. Good luck to all. 13. ” ~@sarge17 Last edited by sarge17 : 24/02/23 SPL Price at posting: 54. Created with Sketch. 70 Sentiment: Sell Disclosure: HeldNot only did AZ not announce completion of Phase 1 with stellar results, the commencement of Phase 2 and a big milestone payment to SPL as the pompom brigade were postulating, it was just interim Phase 1 results and. 0¢. Since September 2020 the. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . The reason I loaded up in the year post the last agm was because we we falsely told that vivagel would would be launched in Q1. Created with Sketch. And somebody must be buying all the shares that are being sold. 0. 0¢ STARPHARMA HOLDINGS LIMITED - Corporate Spotlight . Created with Sketch. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Share Interesting and positive early pre-clinical results. 0012. My theory is we had a large accumulator that was content buying. 10 Year Chart looks like a rollercoaster:But the spike in volume over the past month suggests:a) We're near a huge breakoutORb) We're near a huge. 0000. 166028. 55pm 17/11/2023 ? HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. 1 Introduction. Energy. Enter the title of your abstract. 0¢. Last updated 15. Follow your favourite stocks, view charts, track. S. There appears to be a different behavioural feel about. 1029/9/2000 SPL $0. Created with Sketch. Don’t look to him for the truth lol. ASX - Short Term Trading. 73. Why am am I still positive well let's go through my path to here in 2016/17/18 I was buying shares I bought one package of 100,000 for 66 cents and ended. Hope that SPL starts to deliver on its promises. Join the HotCopper ASX share market forum today for free. ASX - By Stock. Advertise on HotCopper. StarPharma Holdings Ltd. 5¢. 0¢. I wonder if LLoyds are taking the pain on 50% off or if SPL rebating just to get volume and name in market ? LLoyds depending on agreemnet would usually just return stock IMO. The recent announcement about Viraleze nasal spray going into production in Jan 2021, trying to hit the Euro markets in q1-q2 2021, caused a stir in the SP. Latest Posts. AZ will be watching Phase 2 results and assessing the market against the potential SPL bill. For a small cap like spl where the revenue stream created would be very large in the context of our current. Just wondering if anyone else took the time to report Starpharma to the ASX as I did? Remember, NOTHING will ever change if CEOs and Directors of public. Provide some keywords to assist in categorisation of your abstract. Starpharma is a world leader in the development of new medical products based on its proprietary dendrimer technology and has partnerships with leading global companies, including AstraZeneca, MSD (Merck & Co. Created with Sketch. Some years ago SPL failed an FDA trial for the same product when Jackie was CEO. 70% 14. There were 17,468,532 shares dumped on Monday 18/10 and as per M & G notice today only 4,359,271 shares were from M & G on Monday. Canadian Dollar. 83453. Created with Sketch. HotCopper has over 250,000 registered members, and more than 200,000 unique visitors every month and a huge 21 million monthly page impressions.